For the years ended December 31, 2020 and 2019
| Notes | SAR ’000 |
2019
SAR ’000 |
|
| Operating Activities | |||
| Net income | 239,461 | ||
| Adjustments to reconcile net income to net cash provided from operating activities |
|||
| Net accretion of discounts and net amortization of premiums on investments, net |
36,428 | ||
| Net change in accrued special commission income | 193,514 | ||
| Net change in accrued special commission expense | (33,611) | ||
| Net change in deferred loan fees | 27,031 | ||
| Gains on disposals of FVOCI debt securities, net | 22 | (43,518) | |
| Unrealized fair value through profit and loss | (7,350) | ||
| Realized fair value through profit and loss | (3,275) | ||
| Depreciation and amortization | 9 | 143,517 | |
| Loss on sales of property, equipment, and intangibles | 2,629 | ||
| Gain on sale of other real estate | (33,886) | ||
| Gain on sale of an ownership interest in an associate | 8 (b) i | – | |
| Net effect of Commission free deposits from SAMA and SAMA Private Sector Financing Support Program | – | ||
| Provisions for credit and other losses | 38 (a) | 1,342,637 | |
| Share in earnings of associates | 8 (b) | (88,156) | |
| 1,775,421 | |||
| Net (increase) decrease in operating assets: | |||
| Statutory deposit with SAMA | (221,996) | ||
| Due from banks and other financial institutions maturing after three months from acquisition date | (128,566) | ||
| Loans and advances | 800,384 | ||
| Positive fair values of derivatives, net | (60,822) | ||
| Other real estate | 228,525 | ||
| Other assets | (258,546) | ||
| Net increase (decrease) in operating liabilities: | |||
| Due to banks and other financial institutions, net | 1,177,687 | ||
| Customers’ deposits | 5,385,416 | ||
| Negative fair values of derivatives, net | (203,539) | ||
| Other liabilities | 221,110 | ||
| 8,715,074 | |||
| Zakat and Income Tax payments | (476,080) | ||
| Net cash provided from operating activities | 8,238,994 | ||
| Investing Activities | |||
| Proceeds from sales and maturities of investments | 1,939,699 | ||
| Purchases of investments | (2,857,924) | ||
| Dividends received from associates | 8 (b) | 105,709 | |
| Proceeds from sale of an ownership interest in an associate | 8 (b) (i) | – | |
| Acquisitions of property, equipment, and intangibles | 9 | (163,646) | |
| Proceeds from sales of property, equipment, and intangibles | 7,705 | ||
| Net cash used in investing activities | (968,457) | ||
| Financing Activities | |||
| Treasury shares purchased | 37 | (253,531) | |
| Proceeds from Tier I Sukuk | 36 | 215,000 | |
| Redemption of Subordinated debt | (2,000,000) | ||
| Tier I Sukuk costs | (122,024) | ||
| Net cash used in financing activities | (2,160,555) | ||
| Net increase (decrease) in cash and cash equivalents | 5,109,982 | ||
| Cash and cash equivalents | |||
| Cash and cash equivalents at the beginning of the year | 4 (b) | 4,503,172 | |
| Net increase remove/(decrease) in cash and cash equivalents | 5,109,982 | ||
| Cash and cash equivalents at the end of the year | 4 (b) | 9,613,154 | |
| Supplemental special commission information | |||
| Special commission received | 4,096,002 | ||
| Special commission paid | 1,661,263 | ||
| Supplemental non-cash information | |||
| Total other comprehensive income | 522,033 | ||
| Adoption of IFRS 16 on January 1, 2019 | 246,601 | ||
| Other real estate | 121,285 |
The accompanying Notes 1 to 43 form an integral part of these Consolidated Financial Statements.